Significant Ownership of Decheng Capital Global Life Sciences Fund IV, L.P.

Signature - Title
/s/ Xiangmin Cui - By Decheng Capital Management IV (Cayman), LLC, its General Partner, By Xiangmin Cui, Manager
Location
Grand Cayman, Cayman Islands
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Decheng Capital Global Life Sciences Fund IV, L.P..

Notify me when Decheng Capital Global Life Sciences Fund IV, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Decheng Capital Global Life Sciences Fund IV, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
AARD Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 per share 18% 3,917,299 Xiangmin Cui 14 Feb 2025
CGON CG ONCOLOGY, INC. Common stock, $0.0001 par value per share 8.4% $178,215,582 6,371,669 Xiangmin Cui 31 Dec 2024
UPB Upstream Bio, Inc. Common Stock, par value $0.001 per share 6.1% $29,501,931 3,285,293 Xiangmin Cui 31 Dec 2024

Schedules 13D/G Reported by Decheng Capital Global Life Sciences Fund IV, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.